Dengue fever is an illness that are spread by mosquitoes in tropical areas such as Bali. The common symptoms include headache, high fever, bleeding and shock syndrome.

Benefits of QDENGA Vaccine
- Prevent dengue fever infection under 4 virus stereotypes caused by Aedes aegypti or Aedes Albopictus mosquito bites.

QDENGA Vaccination Schedule
QDENGA Vaccination schedule for children according to Indonesian Pediatric Society recommendations
- 6 to 18 years old: 2 dosages with 3 months gaps in between
QDENGA Vaccination schedule for adults
- 18 to 45 years old: 2 dosages with 3 months gaps in between

Composition of QDENGA Vaccine
For every dosage (0,5 ml) it contains weakened dengue virus of stereotypes 1, 2, 3, and 4 with the amount of 3.3, 3.1, 4.0 and 4.5 log10 PFU per dose respectively.

Side Effects of QDENGA Vaccine
Fever, pain, redness at the injection location, headache, sore muscle.

Contraindication of QDENGA Vaccine
• History of severe allergic reaction to the contents of dengue fever vaccines.
• Pregnant and breastfeeding women.

Immunocompromised individuals (for example individuals with HIV)
Individuals receiving immunosuppressive therapies such as chemotherapy or high doses of systemic corticosteroids within 4 weeks prior to vaccination.